By Mauro Orru Novartis's generics-and-biosimilars division Sandoz was granted marketing authorization from the European Commission to commercialize and.
By Mauro Orru Novartis's generics-and-biosimilars division Sandoz entered into an agreement with Samsung Bioepis to commercialize in Europe and North America.
By Robb M. Stewart Bausch + Lomb is offering $1.4 billion in debt and is looking to secure an incremental term loan facility to help finance the planned.
By Mauro Orru Novartis said new data from a late-phase trial showed that its Leqvio injection is effective at reducing cholesterol levels beyond six years in.
By Adria Calatayud Novartis's Sandoz generic-drugs unit has received approval from the U.S. Food and Drug Administration for biosimilar medicine Tyruko to.